<font color="red">Bolus_1</font> <font color="red">injection_1</font> <font color="red">of_1</font> <font color="red">contrast_1</font> <font color="red">agents_1</font> with various iodine concentrations and delivery rates for intracranial three - dimensional CT angiography : evaluation of intracranial arteriovenous contrast using a multidetector - row CT scanner . 
<br>
<br> PURPOSE We evaluated the difference in computed tomography ( CT ) attenuation values of the intracranial arterial and venous systems among the various <font color="red">contrast_1</font> <font color="red">injection_1</font> protocols ( <font color="red">higher_1</font> <font color="red">iodine_1</font> delivery rate or <font color="red">higher_1</font> <font color="red">concentration_1</font> of the agent ) on the source images of intracranial three - dimensional <font color="red">CT_1</font> <font color="red">angiography_1</font> ( 3D - CTA ) using a <font color="red">multidetector_2</font> <font color="red">-_2</font> <font color="red">row_2</font> <font color="red">CT_2</font> <font color="red">(_2</font> <font color="red">MDCT_2</font> <font color="red">)_2</font> <font color="red">scanner_2</font> <font color="red">._2</font> 
<br> MATERIALS AND METHODS We used <font color="red">100_2</font> <font color="red">ml_2</font> <font color="red">of_3</font> <font color="red">iopamidol_6</font> <font color="red">300_4</font> <font color="red">at_2</font> <font color="red">an_2</font> <font color="red">injection_2</font> <font color="red">rate_2</font> <font color="red">of_2</font> <font color="red">3.0_2</font> <font color="red">ml_2</font> <font color="red">/_2</font> <font color="red">s_2</font> <font color="red">,_2</font> <font color="red">100_3</font> <font color="red">ml_3</font> <font color="red">of_3</font> <font color="red">iopamidol_5</font> <font color="red">300_2</font> <font color="red">at_2</font> <font color="red">an_2</font> <font color="red">injection_2</font> <font color="red">rate_2</font> <font color="red">of_2</font> <font color="red">3.7_2</font> <font color="red">ml_2</font> <font color="red">/_2</font> <font color="red">s_2</font> <font color="red">,_2</font> <font color="red">and_2</font> <font color="red">80_3</font> <font color="red">ml_3</font> <font color="red">of_3</font> <font color="red">iopamidol_5</font> <font color="red">370_2</font> <font color="red">at_1</font> <font color="red">an_1</font> <font color="red">injection_1</font> <font color="red">rate_1</font> <font color="red">of_1</font> <font color="red">3.0_1</font> <font color="red">ml_1</font> <font color="red">/_1</font> <font color="red">s_1</font> <font color="red">._1</font> There were 10 patients in each group . Attenuation values of the bilateral internal carotid arteries ( ICAs ) , basilar artery trunk , bilateral cavernous sinuses ( CSs ) , and Galenic vein were measured quantitatively on the axial CT angiographic source images obtained by four - channel MDCT . 
<br> RESULTS Injection of the <font color="red">high_1</font> <font color="red">-_1</font> <font color="red">concentration_1</font> <font color="red">contrast_1</font> with a <font color="red">higher_1</font> <font color="red">iodine_1</font> <font color="red">-_1</font> <font color="red">delivery_1</font> rate achieved good arteriovenous contrast at the cavernous portion . With the same rate of <font color="red">iodine_1</font> delivery , injection of the <font color="red">intermediate_1</font> <font color="red">concentrate_1</font> <font color="red">agent_1</font> increased the CT value of not only the ICAs but also the CSs . 
<br> CONCLUSION <font color="red">High_1</font> <font color="red">-_1</font> <font color="red">concentration_1</font> <font color="red">contrast_1</font> could increase ICA attenuation without intracavernous attenuation gain during the " first - pass " phase .